chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Insomnia, Pain, Pruritus, Rash
Clinical narrative: No sleep; Arms and legs felt like a gravel road; After second shot, hives all over her body except hands feet and stomach; Itched all over my body; Got little pain sparks all over my body; Face was flushed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (After second shot, hives all over her body except hands feet and stomach), FLUSHING (Face was flushed), PRURITUS (Itched all over my body), PAIN (Got little pain sparks all over my body) and INSOMNIA (No sleep) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  No concomitant medication reported.  Concomitant products included STRONTIUM CITRATE from 30-May-2017 to an unknown date for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FLUSHING (Face was flushed). On 07-Mar-2021, the patient experienced URTICARIA (After second shot, hives all over her body except hands feet and stomach), PRURITUS (Itched all over my body) and PAIN (Got little pain sparks all over my body). 07-Mar-2021, the patient experienced RASH (Arms and legs felt like a gravel road). On an unknown date, the patient experienced INSOMNIA (No sleep). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; CORTISONE at a dose of 1 dosage form and PREDNISONE from 10-Mar-2021 to 17-Mar-2021 at a dose of 1 mg four times per day. At the time of the report, URTICARIA (After second shot, hives all over her body except hands feet and stomach), PRURITUS (Itched all over my body), PAIN (Got little pain sparks all over my body), INSOMNIA (No sleep) and RASH (Arms and legs felt like a gravel road) outcome was unknown and FLUSHING (Face was flushed) had not resolved. Not Provided          Concomitant medications included Seraplex.   This case was linked to MOD-2021-039270 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Additional events and patient treatment details were updated.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: No sleep; Arms and legs felt like a gravel road; After second shot, hives all over her body except hands feet and stomach; Itched all over my body; Got little pain sparks all over my body; Face was flushed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URTICARIA (After second shot, hives all over her body except hands feet and stomach), FLUSHING (Face was flushed), PRURITUS (Itched all over my body), PAIN (Got little pain sparks all over my body) and INSOMNIA (No sleep) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  No concomitant medication reported.  Concomitant products included STRONTIUM CITRATE from 30-May-2017 to an unknown date for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FLUSHING (Face was flushed). On 07-Mar-2021, the patient experienced URTICARIA (After second shot, hives all over her body except hands feet and stomach), PRURITUS (Itched all over my body) and PAIN (Got little pain sparks all over my body). 07-Mar-2021, the patient experienced RASH (Arms and legs felt like a gravel road). On an unknown date, the patient experienced INSOMNIA (No sleep). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; CORTISONE at a dose of 1 dosage form and PREDNISONE from 10-Mar-2021 to 17-Mar-2021 at a dose of 1 mg four times per day. At the time of the report, URTICARIA (After second shot, hives all over her body except hands feet and stomach), PRURITUS (Itched all over my body), PAIN (Got little pain sparks all over my body), INSOMNIA (No sleep) and RASH (Arms and legs felt like a gravel road) outcome was unknown and FLUSHING (Face was flushed) had not resolved. Not Provided          Concomitant medications included Seraplex.   This case was linked to MOD-2021-039270 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Additional events and patient treatment details were updated.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of adverse event (possible side effect) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# unknown) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced adverse event (possible side effect). At the time of the report, adverse event (possible side effect) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant medications and treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Lethargy, Pelvic pain
Clinical narrative: Very very slight little sensation enough to know that there is something; Very sharp pain in the pelvis area; Lethargic, like a zombie, very tired; Lethargic, like a zombie, very tired; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic, like a zombie, very tired), FATIGUE (Lethargic, like a zombie, very tired), PELVIC PAIN (Very sharp pain in the pelvis area) and DISCOMFORT (Very very slight little sensation enough to know that there is something) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced LETHARGY (Lethargic, like a zombie, very tired) and FATIGUE (Lethargic, like a zombie, very tired). On 28-Jan-2021, the patient experienced PELVIC PAIN (Very sharp pain in the pelvis area). On 02-Feb-2021, the patient experienced DISCOMFORT (Very very slight little sensation enough to know that there is something). On 29-Jan-2021, PELVIC PAIN (Very sharp pain in the pelvis area) had resolved. On 02-Feb-2021, DISCOMFORT (Very very slight little sensation enough to know that there is something) had resolved. At the time of the report, LETHARGY (Lethargic, like a zombie, very tired) and FATIGUE (Lethargic, like a zombie, very tired) outcome was unknown. Not Provided          Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: 1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced ACCIDENTAL OVERDOSE (1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine). On 09-Jun-2021, ACCIDENTAL OVERDOSE (1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products were reported. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Myalgia, Nausea
Clinical narrative: Didn't feel good; Body aches / Left arm was extremely sore; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Didn't feel good), MYALGIA (Body aches / Left arm was extremely sore) and NAUSEA (Nauseous) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056AZ1A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Didn't feel good), MYALGIA (Body aches / Left arm was extremely sore) and NAUSEA (Nauseous). At the time of the report, FEELING ABNORMAL (Didn't feel good), MYALGIA (Body aches / Left arm was extremely sore) and NAUSEA (Nauseous) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment information were reported.   This case was linked to MOD-2021-214935 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up received contains updated event outcome to recovered/resolved
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: low grade fever; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (low grade fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (low grade fever). At the time of the report, PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information were not provided by the reporter Treatment information were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Neck pain, Vaccination site swelling
Clinical narrative: neck pain; swelling on injection site; headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), VACCINATION SITE SWELLING (swelling on injection site) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (neck pain), VACCINATION SITE SWELLING (swelling on injection site) and HEADACHE (headache). At the time of the report, NECK PAIN (neck pain), VACCINATION SITE SWELLING (swelling on injection site) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment information not provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Arthralgia, Fatigue, Gait disturbance, Myalgia
Clinical narrative: Could hardly walk; Her hair is still falling out (practically bold); Taking a lot of naps; Pain in muscles; Pain in joints; Feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Could hardly walk), ALOPECIA (Her hair is still falling out (practically bold)), SOMNOLENCE (Taking a lot of naps), MYALGIA (Pain in muscles) and ARTHRALGIA (Pain in joints) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 056AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Hair loss (Her hair was falling out at that time and continues to be falling out).   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (Could hardly walk), ALOPECIA (Her hair is still falling out (practically bold)), SOMNOLENCE (Taking a lot of naps), MYALGIA (Pain in muscles), ARTHRALGIA (Pain in joints) and FATIGUE (Feeling very tired). The patient was treated with IBUPROFEN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (Could hardly walk), SOMNOLENCE (Taking a lot of naps), MYALGIA (Pain in muscles), ARTHRALGIA (Pain in joints) and FATIGUE (Feeling very tired) had resolved and ALOPECIA (Her hair is still falling out (practically bold)) had not resolved.      No concomitant medications were reported.  Treatment details also included hair growth products.   This case was linked to MOD-2021-214932 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Events outcome was updated from unknown to recovered.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Could hardly walk; Her hair is still falling out (practically bold); Taking a lot of naps; Pain in muscles; Pain in joints; Feeling very tired; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Could hardly walk), ALOPECIA (Her hair is still falling out (practically bold)), SOMNOLENCE (Taking a lot of naps), MYALGIA (Pain in muscles) and ARTHRALGIA (Pain in joints) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 056AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Hair loss (Her hair was falling out at that time and continues to be falling out).   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (Could hardly walk), ALOPECIA (Her hair is still falling out (practically bold)), SOMNOLENCE (Taking a lot of naps), MYALGIA (Pain in muscles), ARTHRALGIA (Pain in joints) and FATIGUE (Feeling very tired). The patient was treated with IBUPROFEN at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (Could hardly walk), SOMNOLENCE (Taking a lot of naps), MYALGIA (Pain in muscles), ARTHRALGIA (Pain in joints) and FATIGUE (Feeling very tired) had resolved and ALOPECIA (Her hair is still falling out (practically bold)) had not resolved.      No concomitant medications were reported.  Treatment details also included hair growth products.   This case was linked to MOD-2021-214932 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Events outcome was updated from unknown to recovered.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects from my second shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects from my second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects from my second shot). At the time of the report, VACCINATION COMPLICATION (side effects from my second shot) outcome was unknown.            No Concomitant medications were provided No Treatment information provided
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of rash (all over body) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced rash (all over body). At the time of the report, rash (all over body) outcome: unknown. No concomitant medication or treatment information reported. Action taken with mRNA-1273 in response to the event: not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Contusion, Diarrhoea, Fatigue, Vaccination site pain
Clinical narrative: Bruise; Diarrhea; Where they gave me my shot in my arm is super sore; Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise), DIARRHOEA (Diarrhea), VACCINATION SITE PAIN (Where they gave me my shot in my arm is super sore) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONTUSION (Bruise), DIARRHOEA (Diarrhea), VACCINATION SITE PAIN (Where they gave me my shot in my arm is super sore) and FATIGUE (Fatigue). At the time of the report, CONTUSION (Bruise), DIARRHOEA (Diarrhea), VACCINATION SITE PAIN (Where they gave me my shot in my arm is super sore) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No information about concomitants was provided. No information about treatment medication was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood cholesterol, Menopause, Muscle fatigue, Nasopharyngitis
Clinical narrative: Cold like symptoms; Felt a lot of pain on the right hip prosthesis/ knee pain; Leg tiredness; In menopaused stage; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE FATIGUE (Leg tiredness), MENOPAUSE (In menopaused stage), NASOPHARYNGITIS (Cold like symptoms) and ARTHRALGIA (Felt a lot of pain on the right hip prosthesis/ knee pain) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     Concomitant products included LANSOPRAZOLE, FLURBIPROFEN, ORPHENADRINE and CODEINE PHOSPHATE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced MUSCLE FATIGUE (Leg tiredness), MENOPAUSE (In menopaused stage) and ARTHRALGIA (Felt a lot of pain on the right hip prosthesis/ knee pain). On 15-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold like symptoms). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCLE FATIGUE (Leg tiredness), MENOPAUSE (In menopaused stage), NASOPHARYNGITIS (Cold like symptoms) and ARTHRALGIA (Felt a lot of pain on the right hip prosthesis/ knee pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer, Full blood count, Headache, Magnetic resonance imaging, Magnetic resonance imaging head
Clinical narrative: Nerve pain affecting left-side of body; Left-side of body tingling; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain affecting left-side of body), PARAESTHESIA (Left-side of body tingling) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     The patient's past medical history included Sciatica (Patient reports as becoming exacerbated after appearance of AE.).    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced NEURALGIA (Nerve pain affecting left-side of body), PARAESTHESIA (Left-side of body tingling) and HEADACHE (Headache). The patient was treated with METHYLPREDNISOLONE ACETATE (MEDROL [METHYLPREDNISOLONE ACETATE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 22-May-2021, HEADACHE (Headache) outcome was unknown. At the time of the report, NEURALGIA (Nerve pain affecting left-side of body) and PARAESTHESIA (Left-side of body tingling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jun-2021, Fibrin D dimer: negative (Negative) Negative. On 06-Jun-2021, Full blood count: negative (Negative) Negative. On 06-Jun-2021, Magnetic resonance imaging: negative (Negative) Negative and negative (Negative) Negative. On 06-Jun-2021, Magnetic resonance imaging head: negative (Negative) Negative. On 06-Jun-2021, Metabolic function test: negative (Negative) Negative. On 06-Jun-2021, Rheumatoid arthritis: negative (Negative) Negative. On 06-Jun-2021, Troponin: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medicines were reported.
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Neuralgia, Paraesthesia, Rheumatoid arthritis, Troponin
Clinical narrative: Nerve pain affecting left-side of body; Left-side of body tingling; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (Nerve pain affecting left-side of body), PARAESTHESIA (Left-side of body tingling) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     The patient's past medical history included Sciatica (Patient reports as becoming exacerbated after appearance of AE.).    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced NEURALGIA (Nerve pain affecting left-side of body), PARAESTHESIA (Left-side of body tingling) and HEADACHE (Headache). The patient was treated with METHYLPREDNISOLONE ACETATE (MEDROL [METHYLPREDNISOLONE ACETATE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at a dose of UNK dosage form. On 22-May-2021, HEADACHE (Headache) outcome was unknown. At the time of the report, NEURALGIA (Nerve pain affecting left-side of body) and PARAESTHESIA (Left-side of body tingling) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jun-2021, Fibrin D dimer: negative (Negative) Negative. On 06-Jun-2021, Full blood count: negative (Negative) Negative. On 06-Jun-2021, Magnetic resonance imaging: negative (Negative) Negative and negative (Negative) Negative. On 06-Jun-2021, Magnetic resonance imaging head: negative (Negative) Negative. On 06-Jun-2021, Metabolic function test: negative (Negative) Negative. On 06-Jun-2021, Rheumatoid arthritis: negative (Negative) Negative. On 06-Jun-2021, Troponin: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medicines were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: So sick after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (So sick after the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (So sick after the second dose). At the time of the report, VACCINATION COMPLICATION (So sick after the second dose) outcome was unknown.            No concomitant medicines were reported. No treatment information were reported.  Action taken with the drug in response to events was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose, Anxiety
Clinical narrative: Anxious and has anxiety; Receives third dose of Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxious and has anxiety) and ACCIDENTAL OVERDOSE (Receives third dose of Moderna COVID-19 vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced ANXIETY (Anxious and has anxiety) and ACCIDENTAL OVERDOSE (Receives third dose of Moderna COVID-19 vaccine). On 09-Jun-2021, ACCIDENTAL OVERDOSE (Receives third dose of Moderna COVID-19 vaccine) had resolved. At the time of the report, ANXIETY (Anxious and has anxiety) outcome was unknown.            Concomitant products were included medication for diabetes and high blood pressure . No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site swelling
Clinical narrative: Lump; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lump) and VACCINATION SITE SWELLING (Swelling) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PRAVASTATIN for Hypercholesteraemia, VALSARTAN and AMLODIPINE for Hypertension, FENOFIBRATE for Hypertriglyceridemia.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE MASS (Lump) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE MASS (Lump) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details were not provided.  Action taken with mRNA-1273 in response to the event was not applicable.  Patient's lump and swelling was not as bad as after getting the first dose.   This case was linked to MOD-2021-013865 (Patient Link).
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received 2nd dose less than 25 days after receiving 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose less than 25 days after receiving 1st dose) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose less than 25 days after receiving 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose less than 25 days after receiving 1st dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were provided.  No concomitant medication were provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: first shot about 2 months ago; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first shot about 2 months ago) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first shot about 2 months ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first shot about 2 months ago) had resolved.            No concomitant medication information provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccine and humaira effects/Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccine and humaira effects/Side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccine and humaira effects/Side effects). At the time of the report, VACCINATION COMPLICATION (Vaccine and humaira effects/Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Mistakenly administered the yesterday's vial to 1 patient for their 2nd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Mistakenly administered the yesterday's vial to 1 patient for their 2nd dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Mistakenly administered the yesterday's vial to 1 patient for their 2nd dose). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Mistakenly administered the yesterday's vial to 1 patient for their 2nd dose) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Facial pain, Vaccination site haemorrhage, Vaccination site pain
Clinical narrative: Right sided facial pain that resembled sinus infection pain; Lot of bleeding at injection site after the vaccine; Soreness at injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of FACIAL PAIN (Right sided facial pain that resembled sinus infection pain), VACCINATION SITE HAEMORRHAGE (Lot of bleeding at injection site after the vaccine) and VACCINATION SITE PAIN (Soreness at injection site) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jun-2021, the patient experienced FACIAL PAIN (Right sided facial pain that resembled sinus infection pain), VACCINATION SITE HAEMORRHAGE (Lot of bleeding at injection site after the vaccine) and VACCINATION SITE PAIN (Soreness at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FACIAL PAIN (Right sided facial pain that resembled sinus infection pain), VACCINATION SITE HAEMORRHAGE (Lot of bleeding at injection site after the vaccine) and VACCINATION SITE PAIN (Soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Added vaccine information (site of vaccination, expiry date) updated.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Polymerase chain reaction positive, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: My Husband is positive/husband tested for COVID19 on 02JUN2021./ On 05JUN2021 his PCR test was positive./a rapid test on 06JUN2021 and it was also positive; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (My Husband is positive/husband tested for COVID19 on 02JUN2021./ On 05JUN2021 his PCR test was positive./a rapid test on 06JUN2021 and it was also positive) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Antibiotic therapy on 07-Jun-2021.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Jun-2021, the patient experienced COVID-19 (My Husband is positive/husband tested for COVID19 on 02JUN2021./ On 05JUN2021 his PCR test was positive./a rapid test on 06JUN2021 and it was also positive). At the time of the report, COVID-19 (My Husband is positive/husband tested for COVID19 on 02JUN2021./ On 05JUN2021 his PCR test was positive./a rapid test on 06JUN2021 and it was also positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jun-2021, Polymerase chain reaction positive: 05-jun-2021. On 02-Jun-2021, SARS-CoV-2 test: 06-jun-2021 Positive. On 02-Jun-2021, SARS-CoV-2 test positive: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment with Regeneron was reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Pronounced joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pronounced joint pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Pronounced joint pain). At the time of the report, ARTHRALGIA (Pronounced joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.    Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Interchange of vaccine products
Clinical narrative: Received 2nd dose less than 25 days after receiving 1st dose; Received 1st dose of Pfizer and 2nd dose of moderna vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose less than 25 days after receiving 1st dose) and INTERCHANGE OF VACCINE PRODUCTS (Received 1st dose of Pfizer and 2nd dose of moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose less than 25 days after receiving 1st dose) and INTERCHANGE OF VACCINE PRODUCTS (Received 1st dose of Pfizer and 2nd dose of moderna vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose less than 25 days after receiving 1st dose) and INTERCHANGE OF VACCINE PRODUCTS (Received 1st dose of Pfizer and 2nd dose of moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not reported. Treatment information as not reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: First Dose Pfizer, Second Dose Moderna; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (First Dose Pfizer, Second Dose Moderna) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (First Dose Pfizer, Second Dose Moderna). On 09-Jun-2021, INTERCHANGE OF VACCINE PRODUCTS (First Dose Pfizer, Second Dose Moderna) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was reported.  No treatment medication information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: The follow up received is non significant no new information was updated
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Nausea, Vaccination site pain
Clinical narrative: Diarrhea; Nausea; Fatigue; Headache; Pain in the injection site; Swelling in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), HEADACHE (Headache), VACCINATION SITE PAIN (Pain in the injection site), VACCINATION SITE SWELLING (Swelling in the injection site) and NAUSEA (Nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced HEADACHE (Headache), VACCINATION SITE PAIN (Pain in the injection site) and VACCINATION SITE SWELLING (Swelling in the injection site). On 16-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, DIARRHOEA (Diarrhea), HEADACHE (Headache), VACCINATION SITE PAIN (Pain in the injection site), VACCINATION SITE SWELLING (Swelling in the injection site), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Diarrhea; Nausea; Fatigue; Headache; Pain in the injection site; Swelling in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), HEADACHE (Headache), VACCINATION SITE PAIN (Pain in the injection site), VACCINATION SITE SWELLING (Swelling in the injection site) and NAUSEA (Nausea) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced HEADACHE (Headache), VACCINATION SITE PAIN (Pain in the injection site) and VACCINATION SITE SWELLING (Swelling in the injection site). On 16-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, DIARRHOEA (Diarrhea), HEADACHE (Headache), VACCINATION SITE PAIN (Pain in the injection site), VACCINATION SITE SWELLING (Swelling in the injection site), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased
Clinical narrative: Having a problem with my oxygen level, it has had my level from 2 litters to 4/It has had my level from 2 litters to 4; This spontaneous case was reported by a patient and describes the occurrence of OXYGEN SATURATION DECREASED (Having a problem with my oxygen level, it has had my level from 2 litters to 4/It has had my level from 2 litters to 4) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OXYGEN SATURATION DECREASED (Having a problem with my oxygen level, it has had my level from 2 litters to 4/It has had my level from 2 litters to 4). At the time of the report, OXYGEN SATURATION DECREASED (Having a problem with my oxygen level, it has had my level from 2 litters to 4/It has had my level from 2 litters to 4) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  Patient was treated by increasing the oxygen level.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Reporter information, patient demographics, vaccine information, and treatment were updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of ageusia (loss of taste), arthralgia (joint pain) and pain in extremity (arm pain) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Concomitant products included clonazepam, gabapentin and Wellbutrin (bupropion hydrochloride). On Apr 16, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 16, 2021, patient experienced arthralgia (joint pain). On Apr 17, 2021, patient experienced ageusia (loss of taste). On an unknown date, patient experienced pain in extremity (arm pain). Patient treated with Tylenol (paracetamol) ongoing since an unknown date, 1 dosage form once a day; and codeine ongoing since an unknown date at a dose of 1 dosage form once a day. At the time of the report, ageusia (loss of taste), arthralgia (joint pain) and pain in extremity (arm pain) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: not applicable. No concomitant medication or treatment information reported.